Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 616

1.

Detection of tumor markers including carcinoembryonic antigen, APC, and cyclin D2 in fine-needle aspiration fluid of breast.

Lee A, Kim Y, Han K, Kang CS, Jeon HM, Shim SI.

Arch Pathol Lab Med. 2004 Nov;128(11):1251-6.

PMID:
15508191
2.

Detection of Tumor Markers Including Carcinoembryonic Antigen, APC, and Cyclin D2 in Fine-Needle Aspiration Fluid of Breast.

Lee A, Kim Y, Han K, Kang CS, Jeon HM, Shim SI.

Arch Pathol Lab Med. 2004 Nov;128(11):1251-1256.

PMID:
15506825
3.

Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk.

Lewis CM, Cler LR, Bu DW, Zöchbauer-Müller S, Milchgrub S, Naftalis EZ, Leitch AM, Minna JD, Euhus DM.

Clin Cancer Res. 2005 Jan 1;11(1):166-72.

4.

Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.

Dulaimi E, Hillinck J, Ibanez de Caceres I, Al-Saleem T, Cairns P.

Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6189-93.

5.

Nipple aspirate fluid collection, related factors and relationship between carcinoembryonic antigen in nipple aspirate fluid and breast diseases in women in Harbin, PRC.

Zhao YS, Pang D, Wang F, Xue YW, Gao DN, Li H, Li K, Wang BY, Wang D, Li HY.

Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):732-8. doi: 10.1158/1055-9965.EPI-08-0715.

6.

Inactivation of cyclin D2 gene in prostate cancers by aberrant promoter methylation.

Padar A, Sathyanarayana UG, Suzuki M, Maruyama R, Hsieh JT, Frenkel EP, Minna JD, Gazdar AF.

Clin Cancer Res. 2003 Oct 15;9(13):4730-4.

7.

[Detection and significance of APC gene promoter hypermethylation in serum of breast cancer patients].

Zhang JJ, Ouyang T, Wan WH, Xu GW, Deng GR.

Ai Zheng. 2007 Jan;26(1):44-7. Chinese.

PMID:
17222366
8.

DNA methylation in benign breast epithelium in relation to age and breast cancer risk.

Euhus DM, Bu D, Milchgrub S, Xie XJ, Bian A, Leitch AM, Lewis CM.

Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1051-9. doi: 10.1158/1055-9965.EPI-07-2582.

9.

Quantitative hypermethylation of a small panel of genes augments the diagnostic accuracy in fine-needle aspirate washings of breast lesions.

Jeronimo C, Monteiro P, Henrique R, Dinis-Ribeiro M, Costa I, Costa VL, Filipe L, Carvalho AL, Hoque MO, Pais I, Leal C, Teixeira MR, Sidransky D.

Breast Cancer Res Treat. 2008 May;109(1):27-34. Epub 2007 Jun 5.

PMID:
17549626
10.

[Detection of free tumor-related DNA in the serum of breast cancer patients].

Zhang JJ, Ouyang T, Wan WH, Deng GR.

Zhonghua Zhong Liu Za Zhi. 2007 Aug;29(8):609-13. Chinese.

PMID:
18210882
11.

Nipple fluid carcinoembryonic antigen and prostate-specific antigen in cancer-bearing and tumor-free breasts.

Zhao Y, Verselis SJ, Klar N, Sadowsky NL, Kaelin CM, Smith B, Foretova L, Li FP.

J Clin Oncol. 2001 Mar 1;19(5):1462-7.

PMID:
11230492
12.

Methylation profiling of benign and malignant breast lesions and its application to cytopathology.

Pu RT, Laitala LE, Alli PM, Fackler MJ, Sukumar S, Clark DP.

Mod Pathol. 2003 Nov;16(11):1095-101.

13.

Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARβ2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay.

Yamamoto N, Nakayama T, Kajita M, Miyake T, Iwamoto T, Kim SJ, Sakai A, Ishihara H, Tamaki Y, Noguchi S.

Breast Cancer Res Treat. 2012 Feb;132(1):165-73. doi: 10.1007/s10549-011-1575-2. Epub 2011 May 19.

PMID:
21594664
14.

Detection of lymph node micrometastases by gene promoter hypermethylation in samples obtained by endosonography- guided fine-needle aspiration biopsy.

Pellisé M, Castells A, Ginès A, Agrelo R, Solé M, Castellví-Bel S, Fernández-Esparrach G, Llach J, Esteller M, Bordas JM, Piqué JM.

Clin Cancer Res. 2004 Jul 1;10(13):4444-9.

15.

[Methylation status and protein expression of adenomatous polyposis coli (APC) gene in breast cancer].

Liu Z, Yang L, Cui DX, Liu BL, Zhang XB, Ma WF, Zhang Q.

Ai Zheng. 2007 Jun;26(6):586-90. Chinese.

PMID:
17562262
16.
17.

Gene promoter hypermethylation in ductal lavage fluid from healthy BRCA gene mutation carriers and mutation-negative controls.

Locke I, Kote-Jarai Z, Fackler MJ, Bancroft E, Osin P, Nerurkar A, Izatt L, Pichert G, Gui GP, Eeles RA.

Breast Cancer Res. 2007;9(1):R20.

18.

Atypia and DNA methylation in nipple duct lavage in relation to predicted breast cancer risk.

Euhus DM, Bu D, Ashfaq R, Xie XJ, Bian A, Leitch AM, Lewis CM.

Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1812-21.

19.

Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy.

Rosenbaum E, Hoque MO, Cohen Y, Zahurak M, Eisenberger MA, Epstein JI, Partin AW, Sidransky D.

Clin Cancer Res. 2005 Dec 1;11(23):8321-5.

20.

Quantitative detection of methylated ESR1 and 14-3-3-sigma gene promoters in serum as candidate biomarkers for diagnosis of breast cancer and evaluation of treatment efficacy.

Martínez-Galán J, Torres B, Del Moral R, Muñoz-Gámez JA, Martín-Oliva D, Villalobos M, Núñez MI, Luna Jde D, Oliver FJ, Ruiz de Almodóvar JM.

Cancer Biol Ther. 2008 Jun;7(6):958-65. Epub 2008 Mar 20.

PMID:
18379196
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk